Dr. Michael B. Soyka is a senior physician in the Department of Otorhinolaryngology, Head and Neck Surgery at the University Hospital Zurich, identified clinical and serological markers associated with treatment response to dupilumab in patients with chronic rhinosinusitis with a type 2 inflammatory pattern.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)